EUVIMEDEUVIMED entdecken
Crossref

Comparative Study on Bolus Administration of Dexmedetomidine and Fentanyl for Attenuation of Stress Response during Laryngoscopy and Endotracheal Intubation

Prasanth Prasanth, M. Srinivasa Rao, D. Satyanarayana

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Prasanth Prasanth und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Laryngoscopy and endotracheal intubation are associated with significant sympathetic stimulation, resulting in transient increases in heart rate and blood pressure. Although these responses are generally tolerated in healthy individuals, they may precipitate serious cardiovascular complications in susceptible patients. Various pharmacological agents have been employed to attenuate this stress response. This study compared the efficacy of dexmedetomidine and fentanyl in controlling the hemodynamic response to laryngoscopy and endotracheal intubation.

Aim

To evaluate and compare the effectiveness of intravenous dexmedetomidine and fentanyl in attenuating the hemodynamic stress response during laryngoscopy and endotracheal intubation. Materials and Methods: This prospective randomized comparative study was conducted in 60 ASA I and II patients aged 18–60 years undergoing elective surgeries under general anesthesia. Patients were allocated into two groups of 30 each. Group D received dexmedetomidine 1 μg/kg diluted in 100 mL normal saline over 10 minutes, while Group F received fentanyl 2 μg/kg similarly diluted and administered. Hemodynamic parameters including heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) were recorded at baseline and at 1, 3, 5, and 10 minutes following intubation. Statistical analysis was performed using SPSS version 26.0.

Results

Baseline demographic and hemodynamic parameters were comparable between the groups. Following intubation, Group D demonstrated significantly lower HR, SBP, DBP, and MAP values compared to Group F at most observation intervals. The rise in HR and blood pressure at 1 minute post-intubation was markedly attenuated in the dexmedetomidine group. Hemodynamic parameters returned to baseline earlier and remained more stable in Group D throughout the study period. No significant adverse effects were observed.

Conclusion

Dexmedetomidine 1 μg/kg administered before induction is superior to fentanyl 2 μg/kg in attenuating the hemodynamic stress response associated with laryngoscopy and endotracheal intubation. Its ability to provide better cardiovascular stability makes it a valuable anesthetic adjunct, particularly in patients at risk of adverse cardiovascular events.

Zitieren

APA

Prasanth, P., Rao, M. S., & Satyanarayana, D. (2026). Comparative Study on Bolus Administration of Dexmedetomidine and Fentanyl for Attenuation of Stress Response during Laryngoscopy and Endotracheal Intubation. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.133

Vancouver

Prasanth P, Rao MS, Satyanarayana D. Comparative Study on Bolus Administration of Dexmedetomidine and Fentanyl for Attenuation of Stress Response during Laryngoscopy and Endotracheal Intubation. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.133

BibTeX
@article{Prasanth2026,
  author = {Prasanth, Prasanth and Rao, M. Srinivasa and Satyanarayana, D.},
  title = {Comparative Study on Bolus Administration of Dexmedetomidine and Fentanyl for Attenuation of Stress Response during Laryngoscopy and Endotracheal Intubation},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.133}
}
Kostenlos starten →